Electrophysiologic testing in the management of patients with the Wolff-Parkinson-White syndrome and atrial fibrillation
- 1 June 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 51 (10) , 1623-1628
- https://doi.org/10.1016/0002-9149(83)90198-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.Circulation, 1982
- Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: Technique, application, and efficacy in severely symptomatic preexcitation patientsAmerican Heart Journal, 1982
- Paroxysmal atrial fibrillation in the wolff-parkinson-white syndromeThe American Journal of Cardiology, 1981
- Telephonic Documentation of Paroxysmal Atrioventricular Reentrant Tachycardia in Preexcitation with Recurrent Paroxysmal Atrial FibrillationChest, 1980
- Ventricular Fibrillation in the Wolff-Parkinson-White SyndromeNew England Journal of Medicine, 1979
- Atrial fibrillation in the preexcitation syndromeThe American Journal of Cardiology, 1977
- Mechanisms of spontaneous alternation between reciprocating tachycardia and atrial flutter-fibrillation in the Wolff-Parkinson-White syndrome.Circulation, 1977
- Effects of cycle length on atrial vulnerability.Circulation, 1977
- Wolff-Parkinson-White syndrome. The problem, evaluation, and surgical correction.Circulation, 1975
- Ventricular FibrillationCirculation, 1971